The genetic background of medullary thyroid carcinoma in young patients

被引:0
|
作者
Wiench, M
Wygoda, Z
Gubala, E
Wloch, J
Oczko, M
Jarzab, B
机构
[1] Marie Sklodowska Curie Mem Inst, Ctr Oncol, Dept Nucl Med & Endocrine Oncol, PL-44101 Gliwice, Poland
[2] Marie Sklodowska Curie Mem Inst, Ctr Oncol, Clin Oncol Surg, PL-44101 Gliwice, Poland
关键词
RET protooncogene; polymorphism; genetic predisposition; medullary thyroid carcinoma;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The study was undertaken to evaluate the frequency of RET polymorphisms at codons 769 and 836 in young medullary thyroid carcinoma (MTC) patients, in whom the presence of a known germline mutation has been excluded. 40 patients aged 10-29 were subjected to genetic analysis of RET exons 10, 11, 13, 14 and 16 and compared to 140 older patients. The hereditary component occurred to be very high in young MTC patients: 57% carry the germline mutation, other 28% exhibit at least one rare polymorphic variant of RET The observed allelic frequencies were 38% for polymorphic variant L769CTG and 6% for variant S836AGT The results were significantly higher than those obtained in the group of older patients: 20% and 1% for L769CTG and S836AGT, respectively. Our results speak in favour that the polymorphism in RET codon 769 and 836 may also be a factor predisposing to the development of MTC in young age.
引用
收藏
页码:163 / 164
页数:2
相关论文
共 50 条
  • [41] Not Only RET but NF1 and Chromosomal Instability Are Seen in Young Patients with Sporadic Medullary Thyroid Carcinoma
    Castroneves, Luciana Audi
    Mangone, Flavia Regina Rotea
    Lerario, Antonio Marcondes
    da Cunha Mercante, Ana Maria
    Batista, Rafael Loch
    Barros, Luciana Rodrigues Carvalho
    Ferreira, Carla Vaz
    Farias, Evelin Cavalcante
    Vanderlei, Felipe Augusto Brasileiro
    Maia, Ana Luiza
    Nagai, Maria Aparecida
    Jorge, Alexander Augusto Lima
    Hoff, Ana Oliveira
    JOURNAL OF THE ENDOCRINE SOCIETY, 2024, 8 (06)
  • [42] RAS proto-oncogene in medullary thyroid carcinoma
    Moura, Margarida M.
    Cavaco, Branca M.
    Leite, Valeriano
    ENDOCRINE-RELATED CANCER, 2015, 22 (05) : R235 - R252
  • [43] Medullary Thyroid Carcinoma: a 25-Year Perspective
    Matias-Guiu, Xavier
    De Lellis, Ronald
    ENDOCRINE PATHOLOGY, 2014, 25 (01) : 21 - 29
  • [44] Diagnostic and Surgical Dilemmas in Hereditary Medullary Thyroid Carcinoma
    Allen, Shawn M.
    Bodenner, Donald
    Suen, James Y.
    Richter, Gresham T.
    LARYNGOSCOPE, 2009, 119 (07) : 1303 - 1311
  • [45] Rapid Response to Sorafenib in Metastatic Medullary Thyroid Carcinoma
    Frank-Raue, K.
    Ganten, M.
    Kreissl, M. C.
    Raue, F.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2011, 119 (03) : 151 - 155
  • [46] Surgical Management of Medullary Thyroid Carcinoma in Pediatric Age
    Spinelli, Claudio
    Strambi, Silvia
    Rossi, Leonardo
    Elisei, Rossella
    Massimino, Maura
    CURRENT PEDIATRIC REVIEWS, 2016, 12 (04) : 280 - 285
  • [47] Pathological characteristics and genetic features of melanin-producing medullary thyroid carcinoma
    Wang, Changsong
    Yun, Tian
    Wang, Zhicheng
    Meng, Nianlong
    Fan, Naijun
    Lv, Xuexia
    Li, Fulin
    DIAGNOSTIC PATHOLOGY, 2018, 13
  • [48] Pathological characteristics and genetic features of melanin-producing medullary thyroid carcinoma
    Changsong Wang
    Tian Yun
    Zhicheng Wang
    Nianlong Meng
    Naijun Fan
    Xuexia Lv
    Fulin Li
    Diagnostic Pathology, 13
  • [49] A Brief Review on The Molecular Basis of Medullary Thyroid Carcinoma
    Mohammadi, Masoumeh
    Hedayati, Mehdi
    CELL JOURNAL, 2017, 18 (04) : 485 - 492
  • [50] New therapeutic approaches to treat medullary thyroid carcinoma
    Schlumberger, Martin
    Carlomagno, Francesca
    Baudin, Eric
    Bidart, Jean Michel
    Santoro, Massimo
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (01): : 22 - 32